ArticleNeuro-oncology advances

Head-to-head preclinical treatment design prioritizes promising therapies for neurofibromatosis type 1 optic glioma clinical translation.

Talia Eligator et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.